Abstracts

Measuring Intermittent and Daily PrEP Adherence by Hair Levels Self-Report and MEMS Caps Openings

Background: Intermittent PrEP may facilitate adherence, reduce cost, and shows efficacy in simian models, but accurate measurement of adherence is critical for trial interpretation. Hair tenofovir (TFV) levels are strongly and linearly related to dose and predict HIV treatment responses, so may serve as objective markers of adherence. We compared TFV and emtricitabine (FTC) hair…

PrEP Does Not Diminish the Pregnancy Prevention Effectiveness of Hormonal Contraception

Background: Pre-exposure prophylaxis (PrEP) is highly effective for HIV-1 prevention. Some studies have suggested an antagonistic interaction between PrEP and hormonal contraception, with both biologic and behavioral mechanisms hypothesized. Evidence is needed to ensure PrEP and hormonal contraception can be effectively used together. We evaluated whether PrEP reduces hormonal contraceptive effectiveness for pregnancy prevention. Methodology:…

FEM-PrEP: Participant Explanations for Non-Adherence

Background: FEM-PrEP – a clinical trial of daily emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) for HIV prevention – was unable to determine the effectiveness of FTC/TDF among women in sub-Saharan Africa due to low study product adherence. We implemented a follow-up study to identify factors that influenced participants’ non-adherence and reasons for participation. Methodology: We conducted qualitative,…

Willingness to Use Pre-Exposure Prophylaxis Among Community-Recruited Injection Drug Users

Background: Recent evidence indicates that using antiretrovirals as pre-exposure prophylaxis (PrEP) among injection drug users (IDUs) is effective in preventing HIV transmission. We examined the correlates of the willingness to use PrEP among community-recruited active IDUs in Washington, DC. Methodology: Data from the IDU cycle (2012) of the National HIV Behavioral Surveillance system in DC…

HIV Infection and Related Biomarkers Are Independent Risk Factors for Radiographic Emphysema

Background: The association between HIV infection and emphysema remains incompletely understood. We hypothesized that HIV is an independent risk factor for emphysema severity, and explored whether markers of HIV disease and systemic biomarkers of inflammation (interleukin-6 [IL-6]), altered coagulation (D-dimer) and immune activation (soluble CD14 [sCD14]) are associated with emphysema. Methodology: We performed a cross-sectional…

Factors Associated With Chronic Obstructive Pulmonary Disease in a High Risk HIV-Infected Cohort

Background: HIV-infected subjects have been reported to be at higher risk of Chronic Obstructive Pulmonary Disease (COPD) than the general population, due to an increased prevalence and magnitude of exposure hazards, such as smoking, and possible interactions with HIV-infection. We sought to study factors associated with COPD in an HIV-infected cohort with an important smoking…